Skye Bioscience, Inc. (NasdaqCM: SKYE)
Health Care · Biotechnology · US
$1.55
-8.28% today · -85.4% 1Y
Skye Bioscience, Inc. (NasdaqCM: SKYE) operates in the Biotechnology industry within the Health Care sector. The company is valued at $6.86M and employs 2 people.
Over the last twelve months the share price has lost 85.4%, trading between 1.50 and 13.28.
Tweenvest scores Skye Bioscience, Inc. across four factors: quality 29/100, value 21/100. Its strongest factor is quality.
SKYE price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $6.86M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -10.24
- Dividend yield
- —
- Beta (5Y)
- 2.86
- 52-week high
- $13.28
- 52-week low
- $1.50
- Avg volume (3M)
- —
- Shares outstanding
- 4.43M
- Employees
- 2
- Next earnings
- —
About Skye Bioscience, Inc.
Skye Bioscience, Inc., a clinical-stage biotechnology company, focuses on developing molecules that modulate G-protein-coupled receptors (GPCRs) to treat obesity, overweight, and metabolic diseases. Its lead product candidate is nimacimab, a peripherally restricted negative allosteric modulating antibody targeting cannabinoid receptor 1, a key GPCR involved in metabolic regulation. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. Skye Bioscience, Inc. is headquartered in San Diego, California.
- ISIN
- US83086J2006
- Founded
- 2011
- Listed since
- Jan 6, 2015
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Prostatype Genomics AB (publ)OM: PROGEN | $7.26M | Skr0.10 | +13.29% |
| Zeo ScientifiX, Inc.OTCPK: ZEOX | $7.14M | $0.91 | -23.11% |
| Senti Biosciences Holdings, Inc.NasdaqCM: SNTI | $7.00M | $0.22 | -28.47% |
| Rakovina Therapeutics Inc.TSXV: RKV | $6.93M | CA$0.22 | -2.22% |
| CollPlant Biotechnologies Ltd.NasdaqCM: CLGN | $6.85M | $3.63 | +3.28% |
| FibroBiologics, Inc.NasdaqCM: FBLG | $6.75M | $0.97 | -14.07% |
| Alaunos Therapeutics, Inc.NasdaqCM: TCRT | $6.68M | $2.63 | +234.69% |
| Arctic Bioscience ASOB: ABS | $6.59M | Nkr2.31 | -12.50% |
Figures last refreshed Oct 18, 2026.